Protective Role of Hepassocin against Hepatic Endoplasmic Reticulum Stress in Mice

• Published in: International journal of molecular sciences 2022-11, Vol.23 (21), p.13325
• Main Authors: Yang, Yang, Chen, Hui, Wan, Yue, Dong, Diandian, Wang, Xiaofang, Yao, Songhui, Wang, Pengjun, Xiang, Shensi, Yang, Xiaoming, Yu, Miao
• Format: Article
• Language: English
• Subjects: Activating transcription factor 4; Apoptosis; Binding sites; Biocompatibility; Biological activity; Calcium; Calcium influx; Cell death; Choline; Cytotoxicity; Endoplasmic reticulum; ER stress; Fasting; Fatty liver; hepassocin; Hepatocytes; HPS protein; lipid accumulation; Liver; Liver diseases; liver injury; Methionine; Negative feedback; Nutrient deficiency; Phenotypes; Phosphorylation; Physiology; Protein expression; Protein folding; Protein kinase; Proteins; Signal transduction; Steatosis; Tunicamycin
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms232113325

Hepassocin (HPS) is a hepatokine that has multiple proposed physiological functions. Some of the biological processes in which it is involved are closely related to endoplasmic reticulum (ER) stress, but the role of HPS in the regulation of ER stress remains unclear. Here, we demonstrated that HPS transcription is induced by the protein kinase RNA-like ER kinase (PERK)/activating transcription factor 4 (ATF4) cascade upon ER stress in hepatocytes. Additionally, fasting/refeeding also induced HPS expression in mice liver. The loss of HPS sensitizes hepatocytes to ER stress-related cytotoxicity in vitro, whereas HPS treatment altered these phenotypes. HPS deficiency exacerbates fasting/refeeding-induced ER stress in vivo. The preliminary administration of HPS ameliorates liver steatosis, cell death, and inflammation in mice injected with tunicamycin (TM). The improvement of HPS can be observed even if HPS protein is injected after TM treatment. Furthermore, the administration of an ER stress inhibitor alleviated steatohepatitis in methionine- and choline-deficient (MCD) diet-fed HPS-deficient mice. These results suggest that HPS protects hepatocytes from physiological and pathological ER stress, and that the inactivation of HPS signaling aggravating ER stress may be a novel mechanism that drives the development of steatohepatitis. The protective mechanism of HPS against ER stress in hepatocytes was associated with the regulation of ER calcium handling, and the suppression of calcium influx release from ER upon stressor treatment. Collectively, our findings indicate that HPS may act in a negative feedback fashion to regulate hepatic ER stress and protect hepatocytes from ER stress-related injury. HPS has the potential to be a candidate drug for the treatment of ER stress-related liver injury.